Comment on Patient Adherence to Novel Oral Anticoagulants (NOACs) for the Treatment of Atrial Fibrillation and Occurrence of Associated Bleeding Events: A Systematic Review and Meta-analysis

Curr Vasc Pharmacol. 2019;17(4):350-351. doi: 10.2174/1570161116999180613091623.

Authors

Valerie Albert¹, Isabelle Arnet¹, Sajni Gudka²

Affiliations

¹ Pharmaceutical Care Research Group, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
² School of Allied Health, University of Western Australia, Perth, Australia.

PMID: 31218946
DOI: 10.2174/1570161116999180613091623

No abstract available

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Publication types

Letter
Comment

MeSH terms

Administration, Oral
Anticoagulants
Atrial Fibrillation*
Hemorrhage
Humans
Patient Compliance
Stroke*

Substances

Anticoagulants